- Home
- Local News
- Sports
- Business
- Entertainment
- Life
- Opinion
- Photos & Video
- Help
- Jobs
- Cars
- Homes
- Classifieds & Deals
- Local Directory
WEST CHESTER TWP. — The first once-weekly treatment for type 2 diabetes in the U.S. made by Amylin Pharmaceuticals is now available by prescription, the company announced.
The U.S. Food and Drug Administration approved Bydureon Jan. 27. Bydureon is produced locally at Amylin’s West Chester Twp. manufacturing plant on Trade Port Drive.
San Diego, Calif.-based Amylin started operating in 2009 its local manufacturing plant, which employs approximately 300 people.
Keep up with business news and get breaking business news alerts with the Dayton B2B e-mail newsletter.
See Sample | Privacy Policy
User comments are not being accepted on this article.